Significance of inducible tachycardia in patients with syncope of unknown origin: a long-term follow-up

The frequency of inducible tachycardia was assessed in patients presenting with syncope whose noninvasive evaluation did not reveal a cause for syncope. It was also determined whether treatment of tachyarrhythmias during programmed electrical stimulation would prevent recurrence of syncope. One hundred five patients were studied and 97 were followed up for a mean period of 25.8 months. Sixty-eight patients (65%) did not have inducible tachycardia. Sixty of these 68 patients could be followed up; 12 (20%) had recurrent syncope. Ventricular or supraventricular tachycardia was inducible in 37 patients (35%). The frequency of organic heart disease was not higher in this group or in those with inducible ventricular tachycardia as compared with those with inducible supraventricular tachycardia. Three patients with inducible ventricular tachycardia died suddenly or were resuscitated from cardiac arrest, and an additional seven had recurrent syncope; thus, the total recurrence rate was 27%. Of 23 patients undergoing effective therapy as predicted by electrophysiologic testing, 3 (14%) had a recurrent event. Results were significantly different in patients receiving ineffective therapy as judged by electrophysiologic testing. Of 13 patients in this latter category, 7 patients (54%) had recurrence of syncope or cardiac arrest (p less than 0.05). In three patients, recurrence took place a mean of 5 months after cessation of therapy; on resumption of effective therapy, no syncope recurred for 15.6 months (p less than 0.025). Tachycardia is frequently induced in patients with syncope of unknown origin, whether or not organic heart disease is present. Treatment of inducible tachycardia may prevent recurrence of syncope.

This article has been cited by other articles:

				B. Olshansky, J. E. Poole, G. Johnson, J. Anderson, A. S. Hellkamp, D. Packer, D. B. Mark, K. L. Lee, G. H. Bardy, and for the SCD-HeFT Investigators Syncope Predicts the Outcome of Cardiomyopathy Patients: Analysis of the SCD-HeFT Study J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1277 - 1282. [Abstract] [Full Text] [PDF]

				B. Brembilla-Perrot, C. Suty-Selton, D. Beurrier, P. Houriez, M. Nippert, A. Terrier de la Chaise, P. Louis, O. Claudon, M. Andronache, A. Abdelaah, et al. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing J. Am. Coll. Cardiol., August 4, 2004; 44(3): 594 - 601. [Abstract] [Full Text] [PDF]

				E. S. Soteriades, J. C. Evans, M. G. Larson, M. H. Chen, L. Chen, E. J. Benjamin, and D. Levy Incidence and Prognosis of Syncope N. Engl. J. Med., September 19, 2002; 347(12): 878 - 885. [Abstract] [Full Text] [PDF]

				S. Mittal, S. C. Hao, S. Iwai, K. M. Stein, S. M. Markowitz, D. J. Slotwiner, and B. B. Lerman Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope J. Am. Coll. Cardiol., August 1, 2001; 38(2): 371 - 376. [Abstract] [Full Text] [PDF]

				B. Brembilla-Perrot, C. Suty-Selton, P. Houriez, O. Claudon, D. Beurrier, and A. T. de la Chaise Value of non-invasive and invasive studies in patients with bundle branch block, syncope and history of myocardial infarction Europace, January 1, 2001; 3(3): 187 - 194. [Abstract] [PDF]

				S. Mittal, S. Iwai, K. M. Stein, S. M. Markowitz, D. J. Slotwiner, and B. B. Lerman Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1082 - 1089. [Abstract] [Full Text] [PDF]

				A. D. Krahn, G. J. Klein, R. Yee, T. Takle-Newhouse, and C. Norris Use of an Extended Monitoring Strategy in Patients With Problematic Syncope Circulation, January 26, 1999; 99(3): 406 - 410. [Abstract] [Full Text] [PDF]

				A. D. Krahn, G. J. Klein, C. Norris, and R. Yee The Etiology of Syncope in Patients With Negative Tilt Table<$DOWNLINK> and Electrophysiological Testing Circulation, October 1, 1995; 92(7): 1819 - 1824. [Abstract] [Full Text]

				G. J. Klein, B. J. Gersh, and R. Yee Electrophysiological Testing : The Final Court of Appeal for Diagnosis of Syncope? Circulation, September 1, 1995; 92(5): 1332 - 1335. [Full Text]

				W. N. Kapoor Evaluation and Management of the Patient With Syncope JAMA, November 11, 1992; 268(18): 2553 - 2560. [Abstract] [PDF]

				J. P. DiMarco and J. T. Philbrick Use of Ambulatory Electrocardiographic (Holter) Monitoring Ann Intern Med, July 1, 1990; 113(1): 53 - 68. [Abstract] [PDF]

				A. S. Manolis, M. Linzer, D. Salem, and N. A. M. Estes III Syncope: Current Diagnostic Evaluation and Management Ann Intern Med, June 1, 1990; 112(11): 850 - 863. [Abstract] [PDF]

				P. Denes, E. Uretz, M. D. Ezri, and J. Borbola Clinical Predictors of Electrophysiologic Findings in Patients With Syncope of Unknown Origin Arch Intern Med, September 1, 1988; 148(9): 1922 - 1928. [Abstract] [PDF]

				P. C. Nalos, M. R. Myers, E. S. Gang, T. Peter, and W. J. Mandel Analytic Reviews: Electrophysiologic Testing in the Intensive Care Unit J Intensive Care Med, September 1, 1987; 2(5): 241 - 259. [Abstract] [PDF]